The demographic datas of chronic granulomatous disease patients and the comparation of the clinical datas before and after interferon-gamma treatment in our country
Date
2013Author
Barlan, Isil
Filiz, Serkan
KOCACIK UYGUN, DİLARA FATMA
Sanal, Ozden
Camcioglu, Yildiz
SOMER, Ayper
KILIÇ GÜLTEKİN, SARA ŞEBNEM
REİSLİ, İSMAİL
PATIROĞLU, TÜRKAN
YILDIRAN, ALİŞAN
ARTAÇ, HASİBE
Metin, Ayse
AKSU, GÜZİDE
Genel, Ferah
Ozturk, Can
Celmeli, Fatih
BİNGÖL, AYŞEN
Yegin, Olcay
Metadata
Show full item recordAbstract
Objective: Chronic granulomatous disease (CGD) is a genetically heterogeneous primary immunodeficiency that is characterised by bacteria and fungal infections with defective phagocytosis. Interferon-gamma (INF-gamma) has diverse roles in the innate and adaptive responses. Despite several decades of work on INF-gamma treatment in CGD, contraversy remains about its use.
Collections
- Makale [92796]